P053: Recurrent somatic copy number alterations and their association with gene expression levels on cancer genes in ovarian serous cystadenocarcinoma

P053: Recurrent somatic copy number alterations and their association with gene expression levels on cancer genes in ovarian serous cystadenocarcinoma

Bibliographic Details
Main Authors:	Hillary Esplen, Richard Yang, Awdhesh Kalia, Zhenya Tang, Guilin Tang, L. Jeffrey Medeiros, Gokce Toruner
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	Genetics in Medicine Open
Online Access:	http://www.sciencedirect.com/science/article/pii/S2949774423000729

Similar Items

Recurrent Somatic Copy Number Alterations and Their Association with Oncogene Expression Levels in High-Grade Ovarian Serous Carcinoma
by: Hillary P. Esplen, et al.
Published: (2023-11-01)

Gastric metastasis of ovarian serous cystadenocarcinoma
by: Yang S
Published: (2018-09-01)

Mining TCGA database for gene expression in ovarian serous cystadenocarcinoma microenvironment
by: Youzheng Xu, et al.
Published: (2021-05-01)

An Immune-Related Gene-Based Signature as Prognostic Tool in Ovarian Serous Cystadenocarcinoma
by: Shi F, et al.
Published: (2021-07-01)

Genome-Wide Identification and Validation of Gene Expression Biomarkers in the Diagnosis of Ovarian Serous Cystadenocarcinoma
by: Francesca Zalfa, et al.
Published: (2022-08-01)

Serous cystadenocarcinoma of the spleen
by: Chung Kuao Chou, MD, et al.
Published: (2017-06-01)

Gene Expression Subtyping Reveals Immune alterations:TCGA Database for Prognosis in Ovarian Serous Cystadenocarcinoma
by: Chunxia Feng, et al.
Published: (2021-09-01)

A novel ferroptosis related gene signature is associated with prognosis in patients with ovarian serous cystadenocarcinoma
by: Zhixiang Yu, et al.
Published: (2021-06-01)

A Rare association of Trousseau’s Syndrome with Ovarian Serous Cystadenocarcinoma
by: Krishna U, et al.
Published: (2015-10-01)

MET Expression Level in Lung Adenocarcinoma Loosely Correlates with <i>MET</i> Copy Number Gain/Amplification and Is a Poor Predictor of Patient Outcome
by: Wei Yin, et al.
Published: (2022-05-01)

Stem Cell-Associated Signatures Help to Predict Diagnosis and Prognosis in Ovarian Serous Cystadenocarcinoma
by: Li Li, et al.
Published: (2023-01-01)

TRPs in Ovarian Serous Cystadenocarcinoma: The Expression Patterns, Prognostic Roles, and Potential Therapeutic Targets
by: Cheng Zhang, et al.
Published: (2022-06-01)

Comprehensive analysis of LDHAP5 pseudogene expression and potential pathogenesis in ovarian serous cystadenocarcinoma
by: Shitong Lin, et al.
Published: (2020-06-01)

Development and Validation of an RNA-Binding Protein-Based Prognostic Model for Ovarian Serous Cystadenocarcinoma
by: Yunan He, et al.
Published: (2020-10-01)

Giant ovarian cystadenocarcinoma
by: Karell Piñón-García, et al.
Published: (2023-10-01)

KRT19 is a Promising Prognostic Biomarker and Associates with Immune Infiltrates in Serous Ovarian Cystadenocarcinoma
by: Sun Z, et al.
Published: (2023-10-01)

Comprehensive analysis of the expression of sodium/potassium-ATPase α subunits and prognosis of ovarian serous cystadenocarcinoma
by: Wei Huang, et al.
Published: (2020-07-01)

Neoplasms in the trocar site and peritoneal papillary serous cystadenocarcinoma
by: Chiung-Ru Lai
Published: (2014-06-01)

Giant mucinous ovarian cystadenocarcinoma
by: Konjić Ferid, et al.
Published: (2015-01-01)

Low expression of acyl-CoA thioesterase 13 is associated with poor prognosis in ovarian serous cystadenocarcinoma
by: Xiaofeng Lv, et al.
Published: (2023-06-01)

High Grade Serous Cystadenocarcinoma of Testis-Case Report of a Rare Ovarian Epithelial Type Tumour
by: Sithara Aravind, et al.
Published: (2017-06-01)

Serous cystadenocarcinoma of the testis: case report of a rare entity
by: Mohammed El Fadli, et al.
Published: (2022-10-01)

Serous cystadenocarcinoma of the pancreas: report of a case and management reflections
by: Bramis K, et al.
Published: (2012-03-01)

A Serous Cystadenocarcinoma of the Pancreas Diagnosed With Lymph Node Metastasis
by: Mustafa Ozsoy, et al.
Published: (2019-01-01)

Identification and validation of a novel anoikis-related signature for predicting prognosis and immune landscape in ovarian serous cystadenocarcinoma
by: Yu-Ting Zhu, et al.
Published: (2023-08-01)

A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma
by: Wenna Guo, et al.
Published: (2018-11-01)

Peritoneal papillary serous cystadenocarcinoma at a previous laparoscopic trocar site
by: Le-Ming Wang, et al.
Published: (2012-09-01)

Social, Genetics and Histopathological Factors Related to <i>Titin</i> (<i>TTN</i>) Gene Mutation and Survival in Women with Ovarian Serous Cystadenocarcinoma: Bioinformatics Analysis
by: Fabiana de Campos Gomes, et al.
Published: (2023-05-01)

The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
by: Philip Smith, et al.
Published: (2023-07-01)

Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer
by: Filipe Correia Martins, et al.
Published: (2022-10-01)

Testicular papillary serous cystadenocarcinoma: a rare case report and review of the literature
by: Sharhriar Zeighami, et al.
Published: (2011-10-01)

Identification of bromodomain-containing proteins prognostic value and expression significance based on a genomic landscape analysis of ovarian serous cystadenocarcinoma
by: Juan Zhang, et al.
Published: (2022-10-01)

ANXA2P2: A Potential Immunological and Prognostic Signature in Ovarian Serous Cystadenocarcinoma via Pan-Carcinoma Synthesis
by: Yanna Zhang, et al.
Published: (2022-02-01)

LPAR1 regulates the development of intratumoral heterogeneity in ovarian serous cystadenocarcinoma by activating the PI3K/AKT signaling pathway
by: Ran Cui, et al.
Published: (2019-07-01)

The circular RNA expression profile in ovarian serous cystadenocarcinoma reveals a complex circRNA–miRNA regulatory network
by: Minhui Zhuang, et al.
Published: (2021-12-01)

Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma
by: Sanaz Jamalzadeh, et al.
Published: (2024-02-01)

"Sea anemone-like ciliated tumor cells" in a case of serous cystadenocarcinoma of the ovary
by: Uma Handa, et al.
Published: (2015-01-01)

ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2/STAT3 pathway and interacting with ESM1
by: Yu-kun Li, et al.
Published: (2024-01-01)

Ovarian mucinous cystadenocarcinoma in an 11-year-old girl
by: Reham S. Alsereihi, et al.
Published: (2022-10-01)

Giant ovarian mucinous cystadenocarcinoma: A case report
by: Bibek Man Shrestha, et al.
Published: (2022-07-01)